Founders Capital Management (Texas)’s Biogen BIIB Stock Holding History

Founders Capital Management (Texas)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-130	Closed	-$25.2K	–	371
2024 Q3	$25.2K	Hold	130	–	–	0.02%	206
2024 Q2	$30.1K	Hold	130	–	–	0.02%	189
2024 Q1	$28K	Hold	130	–	–	0.02%	187
2023 Q4	$33.6K	Hold	130	–	–	0.02%	179
2023 Q3	$33.4K	Hold	130	–	–	0.03%	177
2023 Q2	$37K	Hold	130	–	–	0.03%	163
2023 Q1	$36K	Hold	130	–	–	0.03%	163
2022 Q4	$36K	Hold	130	–	–	0.03%	157
2022 Q3	$35K	Hold	130	–	–	0.03%	152
2022 Q2	$27K	Hold	130	–	–	0.02%	192
2022 Q1	$31K	Hold	130	–	–	0.02%	163
2021 Q4	$31K	Hold	130	–	–	0.02%	163
2021 Q3	$37K	Buy	+130	New	+$42.6K	0.03%	146

Other funds holding BIIB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Founders Capital Management (Texas)'s BIIB Position: Q4 2024 in Review

Founders Capital Management (Texas) sold out of Biogen (BIIB) in Q4 2024, closing a stake of 130 shares — an estimated $25.2K sold.

Founders Capital Management (Texas) first reported a position in BIIB in Q3 2021 and held it in 13 quarters. The position peaked at $37K in Q2 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

Founders Capital Management (Texas) reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
Founders Capital Management (Texas) sold 130 Biogen shares in Q4 2024, an estimated $25.2K.
Founders Capital Management (Texas) first reported a position in Biogen in Q3 2021 and held it in 13 quarters.
Founders Capital Management (Texas)'s Biogen position peaked at $37K in Q2 2023.
876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Founders Capital Management (Texas)'s 13F filing for Q4 2024, filed 13 Jan 2025.